The EU has approved Eisai and Biogen's Leqembi for a subset of patients with early-stage Alzheimer's disease, more than two years after it was filed.

It's not the first time Teva has been judged to have broken European antitrust rules: in November 2020 the EU fined Teva and its neurology unit Cephalon €60.5 million for an elaborate "pay for ...

Our picks of the best gaming TVs of 2025 boast great image quality and minimal delay, and can significantly enhance your gaming sessions.